Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
7.92
+0.47 (6.31%)
At close: Sep 9, 2025, 4:00 PM
7.77
-0.15 (-1.89%)
After-hours: Sep 9, 2025, 7:29 PM EDT

Company Description

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases.

It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.

The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023.

The company was founded in 1996 and is headquartered in Jericho, New York.

Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals logo
CountryUnited States
Founded2018
IPO DateAug 26, 2025
IndustryBiotechnology
SectorHealthcare
CEOJun Liu

Contact Details

Address:
2 Jericho Plaza, Suite 101B
Jericho, New York 11753
United States
Phone718 673 6078
Websitecuranexpharma.com

Stock Details

Ticker SymbolCURX
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$4.00
CIK Code0002025942
ISIN NumberUS23126K1060
Employer ID83-0741390
SIC Code2834

Key Executives

NamePosition
Jun LiuChief Executive Officer, President and Director
Dian Ying JingDirector and Secretary
Haiyan YangChief Financial Officer and Treasurer
Huijuan ZhongChief Science Officer
Liqin XieChief Operating Officer
Ning ZhangChief Technology Officer
Yong YanIndependent Director
Yanming DuIndependent Director
Xiaohui HaoIndependent Director

Latest SEC Filings

DateTypeTitle
Sep 9, 202510-QQuarterly Report
Aug 27, 20258-KCurrent Report
Aug 26, 2025424B4Prospectus
Aug 26, 2025424B4Prospectus
Aug 26, 20258-KCurrent Report
Aug 25, 2025CERTCertification by an exchange approving securities for listing
Aug 25, 20258-A12BRegistration of securities
Aug 12, 2025EFFECTNotice of Effectiveness
Jul 22, 2025FWPFree Writing Prospectus
Jul 18, 2025S-1/A[Amend] General form for registration of securities under the Securities Act of 1933